Artificial Intelligence

Biocon Chair: AI in Clinical Trials Is the Holy Grail

Headline and link to the original report by Bloomberg MarketsHow we report

Bloomberg MarketsOctober 15, 2026

Interestana links to this report without summarising it, because Bloomberg Markets does not allow reuse of its reporting.

Read on Bloomberg Markets

Ref 0045UTCV

Follow this story

Interests

Artificial Intelligence

Get Artificial Intelligence in your inbox — new stories in 40 words or fewer, once a week.

Follow Interestana

Read next

What is it like running a Fortune 500 business? HP’s regional CTO on adopting AI safely and motivating tech teams

Bloomberg Markets

Hyperliquid Founder Yan Seeks US Rules That Spare Its Blockchain

Bloomberg Markets

NYU's Marcus on Why AI May Be a 'Flawed Tool'

Lawyer of arrested OpenAI engineer says allegations are ‘wholly out of character,’ one-way ticket to Saudi Arabia with wife and child was pre-booked